high-dose intermittent therapy, HDIT highly active antiretroviral therapy; HAART hypersensitivity vasculitis hypothyroidism immune reconstruction inflammatory syndrome, IRIS integrase inhibitor interferone-γ release assay, IGRAs International Standards for Tuberculosis Care, ISTC isoniazid kanamycin Kaposi’s sarcoma Kivexa lamivudine latent TB infection, LTBI leukemoid reaction
22 113 128 75 24 114 126 139 21 21 118 115 115 123 11
levofloxacin line probe assay loop diuretics Löwenstein-Jensen (LJ) medium lower lobe Lupus-like syndrome M. avium complex M. haemophilum M. kansasii M. marinum M. xenopi maculopapular rash Mantoux test Middlebrook 7H10 mono- resistance moxifloxacin multidrug- resistance, MDR Mycetoma Mycobacterium africanum Mycobacterium bovis Mycobacterium tuberculosis Complex Mycobacterium tuberculosis myxedma National TB Programme
72 15 72 1 12 68 73 73 73 73 73 60 126 14 8 73 8 11 1 1 1 1 76 139 151